The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Biomarker analysis from a phase I study using gedatolisib+palbociclib+hormone therapy in ER+/HER2- metastatic breast cancer (mBC).
 
Robert Wesolowski
Consulting or Advisory Role - Pfizer; Puma Biotechnology; Roche
Research Funding - Acerta Pharma
Travel, Accommodations, Expenses - Pfizer; Puma Biotechnology; Roche
 
Nuzhat Pathan
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Zhou Zhu
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Erica Michelle Stringer-Reasor
Honoraria - Breast Cancer Index; Lilly; Mylan
Consulting or Advisory Role - Immunomedics
Speakers' Bureau - Lilly
Research Funding - Susan G. Komen for the Cure; V Foundation
Travel, Accommodations, Expenses - Cascadian Therapeutics; Lilly
 
Hyo S. Han
Consulting or Advisory Role - Pfizer
Speakers' Bureau - Lilly; Lilly
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); G1 Therapeutics (Inst); Horizon Oncology Research (Inst); Novartis (Inst); Pfizer (Inst); Prescient Therapeutics (Inst); Seagen (Inst); TapImmune Inc. (Inst); Tesaro (Inst)
 
Elizabeth Claire Dees
Consulting or Advisory Role - G1 Therapeutics; Novartis (I); Strata Oncology
Research Funding - Bayer; Cerulean Pharma; Genentech/Roche; H3 Biomedicine; Lilly; Merck; Meryx Pharmaceuticals; Novartis; Pfizer
Travel, Accommodations, Expenses - G1 Therapeutics
 
Aditya Bardia
Consulting or Advisory Role - bioTheranostics; Genentech; Genentech/Roche (Inst); Immunomedics; Immunomedics (Inst); Innocrin Pharma (Inst); Merck; Novartis; Novartis (Inst); Pfizer; Pfizer (Inst); Puma Biotechnology; Radius Health; Radius Health (Inst); Sanofi; Spectrum Pharmaceuticals
Research Funding - bioTheranostics
 
Rachel M. Layman
Consulting or Advisory Role - GE Healthcare (I); Genomic Health; Novartis; Pfizer; Siemens (I)
Research Funding - GlaxoSmithKline (Inst); Ipsen; Lilly; Novartis (Inst); Pfizer (Inst); Zentalis
 
Amy Weise
No Relationships to Disclose
 
Peter Kabos
Research Funding - Angiochem (Inst); AstraZeneca (Inst); Genentech (Inst); Lilly (Inst); Pfizer (Inst); Radius Health (Inst); Sanofi (Inst)
 
Janice M. Lu
Honoraria - Daiichi Sankyo; Novartis; Pfizer; Puma Biotechnology
Consulting or Advisory Role - Daiichi Sankyo/Lilly; Novartis; Pfizer; Puma Biotechnology
Travel, Accommodations, Expenses - Daiichi Sankyo; Novartis; Pfizer
 
Kenneth Alan Kern
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
Travel, Accommodations, Expenses - Pfizer
 
Kristen J. Pierce
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Hope S. Rugo
Consulting or Advisory Role - Celltrion; Ionis Pharmaceuticals
Research Funding - Daiichi Sankyo (Inst); Eisai (Inst); Genentech (Inst); Immunomedics (Inst); Lilly (Inst); Macrogenics (Inst); Merck (Inst); Novartis (Inst); OBI Pharma (Inst); Odonate Therapeutics (Inst); Pfizer (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Daiichi Sankyo; Macrogenics; Merck; Mylan; Novartis; OBI Pharma; Pfizer; Puma Biotechnology